Company Profile

NanoSUR LLC
Profile last edited on: 7/30/19      CAGE: 7YBZ8      UEI: FA4UJN8L1H13

Business Identifier: Safe and sustainable pesticides efficacious over wide range of pests affecting crops
Year Founded
2017
First Award
2018
Latest Award
2021
Program Status
Active
Popularity Index
Is this YOUR Company?
Ensure accuracy and completeness of YOUR Company Profile by completing the brief Survey Instrument attached
Do you know about this Awardees?
Let us encourage you to provide any data which would enhance the completeness of this firm's profile.

Location Information

1951 NW 7th Avenue Suite 600
Miami, FL 33136
   (202) 701-5532
   info@nanosur.com
   www.nanosur.com
Location: Multiple
Congr. District: 24
County: Miami-Dade

Public Profile

Based in the Cambridge Innovation Center in Miami but with lab facilities also in Madison WI., NanoSUR is organized around development of non-GMO, RNA-based technology that will allow for a more affordable and environmentally benign crop production. While protecting beneficial insects and biodiversity, the firm's work on the development of a new class of materials - MdsRNAs - is structured around enabling farmers worldwide to produce abundant, safe foods that will improve people’s quality of life and health by unlocking the crop protection potential of Nobel-Prize winning technology RNA interference

Extent of SBIR involvement

User Avatar

Synopsis: Awardee Business Condition

Employee Range
5-9
Revenue Range
.5M-1M
VC funded?
No
Public/Private
Privately Held
Stock Info
----
IP Holdings
1-4

Awards Distribution by Agency

Most Recent SBIR Projects

Year Phase Agency Total Amount
2023 2 USDA $1,398,977
Project Title: Development of efficacious RNAi-based baits for RIFA control
2023 2 NSF $1,294,281
Project Title: Development of Broadly Efficacious Ribonucleic Acid Interference Triggers for Pesticides

Key People / Management

  Graciela Arhancet -- President, Founder

  Juan Arhancet -- Founder and Chief Science Officer

  Andrew Fehretdinov -- CFO

  Vladimir Trubetskoy -- Director of Formulation

Company News

There are no news available.